Keyphrases
Neutrophil Activation
100%
Endothelium
100%
Thrombin
100%
Platelet-activating Factor Receptor Antagonist
100%
Platelet-activating Factor
54%
Endothelial Cells
45%
Methionine
27%
Phenylalanine
27%
Leucine
27%
Formyl
27%
Acetate
18%
Incubation
18%
Coagulation
9%
Sepsis
9%
Adhesion
9%
Endothelial Injury
9%
Cell Lysis
9%
Superoxide Production
9%
Fluid Phase
9%
Paracrine
9%
Membrane Phospholipids
9%
Human Umbilical Vein Endothelial Cells (HUVECs)
9%
Neutrophil Response
9%
Cell Detachment
9%
Event Sequences
9%
Priming Effect
9%
Lipid Extract
9%
Elastase Release
9%
BN52021
9%
Antithrombin III (ATIII)
9%
Medicine and Dentistry
Thrombin
100%
Thrombocyte Activating Factor Antagonist
100%
Neutrophil
100%
Platelet-Activating Factor
54%
Endothelial Cell
45%
Granulocyte
45%
Phenylalanine
27%
Leucine
27%
N-Formylmethionine
27%
Incubation
18%
Acetic Acid
18%
Sepsis
9%
Lipid
9%
Disease
9%
Endothelium Injury
9%
Buffer
9%
Cytolysis
9%
Human Umbilical Vein Endothelial Cell
9%
Neutrophil Response
9%
Antithrombin III
9%
Membrane Phospholipid
9%
Ginkgolide B
9%
Superoxide
9%
Elastase
9%
Neuroscience
Receptor Antagonist
100%
Thrombin
100%
Platelet-Activating Factor Receptor
100%
Platelet-Activating Factor
54%
Polymorphonuclear Cell
45%
Leucine
27%
Phenylalanine
27%
N-Formylmethionine
27%
Lipid
9%
Agonist
9%
Cytolysis
9%
Membrane Phospholipid
9%
Antithrombin III
9%
Ginkgolide B
9%
Human Umbilical Vein Endothelial Cell
9%
Elastase
9%
Immunology and Microbiology
Thrombocyte Activating Factor
100%
Neutrophil
100%
Thrombin
100%
Granulocyte
45%
Methionine
27%
Leucine
27%
Phenylalanine
27%
Superoxide
9%
Umbilical Vein Endothelial Cell
9%
Neutrophil Response
9%
Liquid
9%
Agonist
9%
Cytolysis
9%
Extract
9%